Home > PS Ratio > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
PS (Price/Sales) Ratio

The Current P/S Ratio of KILITCH DRUGS (INDIA) is 2.71.

Share Price ₹306.5Mar 10,2025
Market Cap ₹493.5 Cr
Sales-TTM₹181.9 CrTTM-Consolidated Results
Price/Sales2.71xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of KILITCH DRUGS (INDIA)

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of KILITCH DRUGS (INDIA) is calculated as :

Current Market Cap [ ₹493.5 Cr] as on Mar 10,2025

(/) Sales [ ₹181.9 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 2.71x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for KILITCH DRUGS (INDIA) , the investors are currently willing to pay '2.71 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of KILITCH DRUGS (INDIA) !

The chart below summarizes the trend in P/S Ratio of KILITCH DRUGS (INDIA) over the last five years.

Historical PS (Price/Sales) ratio chart of KILITCH DRUGS (INDIA)


PS Ratio Performance Analysis for KILITCH DRUGS (INDIA)

- KILITCH DRUGS (INDIA) 's latest p/e ratio is 2.71x.

- KILITCH DRUGS (INDIA) 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.42x.

- KILITCH DRUGS (INDIA) 's operated at median p/e ratio of 2.29x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, KILITCH DRUGS (INDIA) 's p/e ratio peaked in Mar2024 at 4.06x.

- KILITCH DRUGS (INDIA) 's p/e ratio hit its five-year low in Mar2023 of 1.56x.


How does KILITCH DRUGS (INDIA) 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
KILITCH DRUGS (INDIA) 181.92.71493.5
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.57.49386,569.0
DIVIS LABORATORIES LTD9,078.016.12146,318.0
CIPLA LTD26,981.24.38118,110.0
TORRENT PHARMACEUTICALS LTD11,302.09.20103,926.0
DR REDDYS LABORATORIES LTD31,229.32.9993,471.5
MANKIND PHARMA LTD11,641.08.0193,257.2
ZYDUS LIFESCIENCES LTD22,247.44.0489,876.8
LUPIN LTD22,001.64.1791,732.8
AUROBINDO PHARMA LTD30,921.82.0563,472.9
ABBOTT INDIA LTD6,243.210.4365,100.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KILITCH DRUGS (INDIA) 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.05x
Max industry PS 16.12x
Median industry PS 4.38x
Average industry PS 6.51x



You may also like the below Video Courses